Novo Nordisk AS - Company Profile
Powered by
All the data and insights you need on Novo Nordisk AS in one report.
- Save hours of research time and resources with
our up-to-date Novo Nordisk AS Strategy Report
- Understand Novo Nordisk AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
Novo Nordisk AS Catalyst Calendar
Proactively evaluate Novo Nordisk AS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Novo Nordisk AS Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
31 Aug 2019 | Phase IV Trial Initiation | Novo Nordisk AS | NOVO B | coagulation factor IX (recombinant), glycopegylated LA | Hematological Disorders | Hemophilia B (Factor IX Deficiency) | Clinical Trial Registry |
31 Aug 2019 | Phase II Trial Completion | Kobe University School of Medicine; Novo Nordisk AS | NOVO B | insulin degludec LA | Metabolic Disorders | Type 1 Diabetes (Juvenile Diabetes) | Clinical Trial Registry |
17 Aug 2019 | Phase I Trial Completion | Novo Nordisk AS | NOVO B | NN-9775 | Metabolic Disorders | Obesity | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer